IPD vs MYX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

IPD

IMPEDIMED FPO [IPD]

48LOW

MYX

M PHARMA FPO [MYX]

51MEDIUM

Score Breakdown

IPD MYX
Technical
57
51
Catalyst
55
53
Sentiment
50
50
Fundamental
95
85
Momentum
30
38
Risk Gate
27
42

Key Metrics

IPD Metric MYX
$22.0MMarket Cap$233.2M
6.9MAvg Volume (20d)291K
N/AShort Interest+2.5%
$0.05952-Week High$6.500
$0.00552-Week Low$2.040
+0.0%Daily Change-0.7%
$0.006Reference Price$2.810
-117.9%ROE-20.6%
-171.3%Profit Margin-20.4%

Active Signals

IPD Signals

●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (5 quarters)
●Low P/S ratio (1.5x)
●Strong revenue growth (+25%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Near 52-week low (2% of range)

MYX Signals

●Beating the Small Ords index — relative strength of 1.29, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.6x)
●EPS estimates revised upward (+10pts)
●Near 52-week low (19% of range)
●CANSLIM I: Institutional ownership (36%)
●Deeply negative margins (-20%)

Ask Scout AI to compare IPD and MYX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

IPD vs OCC →IPD vs PKY →IPD vs RAD →IPD vs REG →IPD vs RHY →
IPD Full Analysis → MYX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).